The WTO waiver battle over Covid jab IP rights

Sudden US backing for a global waiver on patent protections for COVID-19 vaccines offers hope to poor nations struggling for doses—but the big pharma industry thinks the notion misguided.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *